Overview: Medical Exam Report TestIntroduction: The Medical Exam Report Test provides a comprehensive report for general health screening, assessing overall health status. Aligned with 2023 USPSTF guidelines, it uses multiple methods (e.g., immunoassay, biochemistry) for high specificity, supporting general screening. This test is critical for guiding health assessments, preventive care, and improving outcomes in clinical pathology for patients undergoing routine health evaluations.
Other Names: MER Assay, General Health Panel.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Comprehensive health screening began in the 1970s with preventive medicine research. Multi-panel testing improved in the 2000s, enhancing diagnostic precision.
Purpose: Provides medical examination report for general health screening, guides preventive care, and evaluates overall health status.
Test Parameters: 1. Medical Exam Report
Pretest Condition: No fasting required. Collect serum, plasma, whole blood, or urine. Report history of chronic conditions or symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL), Whole Blood (EDTA, 2-5 mL), Urine (sterile container, 5-20 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document chronic conditions, fatigue, weight changes, or family history of diseases. Include current medications.
Consent: Written consent required, detailing the tests purpose, health screening implications, and risks of sample collection.
Procedural Considerations: Uses multiple methods (e.g., immunoassay, biochemistry) to generate a comprehensive health report. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for routine health screening.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Incomplete medical history may reduce accuracy.
Clinical Significance: Abnormal results identify health issues (e.g., diabetes, anemia), guiding preventive care or treatment. Normal results support ongoing health monitoring.
Specialist Consultation: Consult a primary care physician for result interpretation and preventive care planning.
Additional Supporting Tests: Lipid panel, glucose testing, or imaging (e.g., chest X-ray) to confirm health status.
Test Limitations: Broad screening may miss specific conditions; clinical correlation is needed. Sample quality affects accuracy.
References: USPSTF Screening Guidelines, 2023; Annals of Internal Medicine, Krist AH, 2022.
